Glycoprotein-Specific Platelet Autoantibodies in Persistent Chemotherapy – Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Andrew B. Song et al., adding:
”Direct glycoprotein – specific platelet autoantibodies detected in a majority of patients with persistent chemotherapy – induced thrombocytopenia.
Persistent chemotherapy – induced thrombocytopenia is usually blamed on cumulative myelosuppression, but immunity may play a part.
Among 55 patients with solid tumors and persistent CIT, 65.4% carried direct platelet autoantibodies, most often against GPIa/IIa (97.2%), at levels comparable to an immune thrombocytopenia cohort.
The finding points to a possible immune-mediated component worth investigating for treatment.”
Title: Direct glycoprotein – specific platelet autoantibodies detected in a majority of patients with persistent chemotherapy – induced thrombocytopenia.
Authors: Andrew B. Song, Brian R. Curtis, Hanny Al-Samkari.
Stay updated on the latest scientific advances with Hemostasis Today.
-
Aug 20, 2026, 16:13Geraldine Walsh: Exploring Blood Components in Transfusion Today
-
Aug 20, 2026, 16:02José Antonio García Erce: Canada Updates Recommendations on Transfusion and Albumin
-
Aug 20, 2026, 16:01Prashant Mehta: Optimizing Inotuzumab Dosing in B-ALL
-
Aug 20, 2026, 15:56Jecko Thachil: Heavy Menstrual Bleeding – Obstacle for Quality of Life
-
Aug 20, 2026, 15:32Ifeanyichukwu Ifechidere: Protein S Deficiency – When the Timing of the Test Matters
-
Aug 20, 2026, 15:25Giuseppe Leone: Sickle Cell Disease and Transfusion-Dependent β-Thalassemia in Adults
-
Aug 20, 2026, 15:15The Cell in Your Bone Marrow Responsible for Making Platelets – ITP Support Association
-
Aug 20, 2026, 15:10Shiny K. Kajal: The Latest ISBT Blood Group Update Is Here
-
Aug 20, 2026, 14:57Spiros Denaxas: The Risk Factor Paradox in Recurrent Heart Disease